However, emerging data have suggested that overexpression and abnormal cytoplasmic localization of p16 may correlate with tumor grade, tumor progression and/or poor prognosis in multiple tumor types including HCC [15–19,24–26,34]. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.